SOLICITATION NOTICE
A -- Cap-dependent endonuclease inhibitors (CENis) - NHRC
- Notice Date
- 5/15/2026 11:47:44 AM
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 541715
— Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Contracting Office
- NAVSUP FLT LOG CTR NORFOLK NORFOLK VA 23511-3392 USA
- ZIP Code
- 23511-3392
- Solicitation Number
- N0018926QB059
- Response Due
- 5/25/2026 2:00:00 PM
- Archive Date
- 06/09/2026
- Point of Contact
- Brian Kinkade, Phone: 7712292412, Jacob Gephart, Phone: 7712292712
- E-Mail Address
-
brian.m.kinkade.civ@us.navy.mil, jacob.n.gephart.civ@us.navy.mil
(brian.m.kinkade.civ@us.navy.mil, jacob.n.gephart.civ@us.navy.mil)
- Small Business Set-Aside
- NONE No Set aside used
- Description
- The preclinical development of Cap-dependent endonuclease inhibitors (CENi), a class of small molecules, as broad-spectrum antiviral therapeutics. The scope of this project includes all activities required to select lead CENi candidates, including in vitro and in vivo efficacy studies and characterization and optimization of lead compounds. This includes Research Support expertise regarding the preclinical development of cap-dependent endonuclease inhibitors (CENis) with viruses that require biosafety level 4 (BSL-4) containment to support the Naval Medical Research Command in Fort Detrick, MD. This work will be performed over a 36-month period.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/workspace/contract/opp/7ca6661dd9ec4edb86296ad3bc28a805/view)
- Place of Performance
- Address: Galveston, TX, USA
- Country: USA
- Country: USA
- Record
- SN07817634-F 20260517/260515230043 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |